Arsenic trioxide was the first example of a therapeutic drug that caused QT prolongation, TdP, and sudden death by reducing the formation of the hERG-chaperone complexes Hsp 70 and Hsp 90 (Ficker et al., 2004; Nogawa and Kawai, 2014). Here, KCNH2 is linked to torsades de pointes.